Aurora Sheboygan Pricing: Bivalirudin Trifluoroacetate 250 Milligrams Intravenous Solution at $79.10
Aurora Medical Center Sheboygan County, located at 3400 Union Ave in Sheboygan, WI, offers a range of medical services, including the administration of Bivalirudin Trifluoroacetate, a medication used primarily as an anticoagulant. This intravenous solution, priced at $79.10 for a 250 milligram dose, is utilized in clinical settings to prevent blood clots, particularly during certain cardiovascular procedures. The cost reflects Aurora Sheboygan’s pricing structure, ensuring patients receive necessary care with transparent billing practices.
What is Bivalirudin Trifluoroacetate used for? – Bivalirudin Trifluoroacetate is used as an anticoagulant to prevent blood clots during certain medical procedures, particularly in patients undergoing percutaneous coronary intervention.
How is Bivalirudin Trifluoroacetate administered? – It is administered intravenously, meaning it is delivered directly into a vein through an IV solution, ensuring rapid and effective action.
Why is Bivalirudin Trifluoroacetate important in medical procedures? – It is crucial for reducing the risk of clot formation during procedures like angioplasty, thereby enhancing patient safety and procedure success rates.
What are the potential side effects of Bivalirudin Trifluoroacetate? – Common side effects may include bleeding, back pain, or nausea, and patients should be monitored for any adverse reactions during treatment.
Is Bivalirudin Trifluoroacetate covered by insurance? – Coverage for Bivalirudin Trifluoroacetate varies by insurance provider, so it is advisable for patients to check with their insurer regarding specific coverage details.
How does the cost of Bivalirudin Trifluoroacetate at Aurora compare to other facilities? – The cost of $79.10 at Aurora Medical Center Sheboygan County is competitive and reflects their commitment to providing affordable healthcare solutions.
Can patients receive Bivalirudin Trifluoroacetate outside of a hospital setting? – Typically, Bivalirudin Trifluoroacetate is administered in a hospital or clinical setting due to the need for professional monitoring during its use.
